| 51 |
27888400 | Repression of CDKN2C caused by PML/RARα binding promotes the proliferation and differentiation block in acute promyelocytic leukemia. | 2016 Dec |
1 |
| 52 |
28959333 | Analysis of Promyelocytic Leukemia in Human Embryonic Carcinoma Stem Cells During Retinoic Acid-Induced Neural Differentiation. | 2016 Sep |
4 |
| 53 |
25514379 | Antagonism between granulocytic maturation and deacetylase inhibitor-induced apoptosis in acute promyelocytic leukaemia cells. | 2015 Jan 20 |
2 |
| 54 |
25692052 | High-Risk Microgranular Acute Promyelocytic Leukemia with a Five-Way Complex Translocation Involving PML-RARA. | 2015 |
1 |
| 55 |
25759405 | A novel clonal t(1;4)(p36.1;q31) translocation in acute promyelocytic leukaemia. | 2015 May |
1 |
| 56 |
25795919 | Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells. | 2015 May 28 |
2 |
| 57 |
25800051 | Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells. | 2015 May 28 |
1 |
| 58 |
25849135 | Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer. | 2015 May |
1 |
| 59 |
25973309 | Reactive oxygen species regulate the differentiation of acute promyelocytic leukemia cells through HMGB1-mediated autophagy. | 2015 |
5 |
| 60 |
26058416 | Synergistic targeted therapy for acute promyelocytic leukaemia: a model of translational research in human cancer. | 2015 Dec |
2 |
| 61 |
26637766 | Acute myeloid leukemia in children and adolescents: identification of new molecular targets brings promise of new therapies. | 2015 |
2 |
| 62 |
26775483 | [Significance of PLSCR1 in Matrine Induced Differentiation of ATRA Resistant APL Cells]. | 2015 Nov |
2 |
| 63 |
26862315 | Central nervous system haemorrhage causing early death in acute promyelocytic leukaemia. | 2015 |
2 |
| 64 |
23770850 | Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia. | 2014 May 22 |
2 |
| 65 |
24566867 | Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392. | 2014 Apr 15 |
3 |
| 66 |
24592821 | Incorporation of arsenic trioxide in induction therapy improves survival of patients with newly diagnosed acute promyelocytic leukaemia. | 2014 Jul |
2 |
| 67 |
24596215 | PML nuclear bodies mediate the therapeutic response of APL cells. | 2014 Mar |
3 |
| 68 |
24907012 | Understanding the molecular pathogenesis of acute promyelocytic leukemia. | 2014 Mar |
2 |
| 69 |
25126724 | MIR125B1 represses the degradation of the PML-RARA oncoprotein by an autophagy-lysosomal pathway in acute promyelocytic leukemia. | 2014 Oct 1 |
1 |
| 70 |
25258343 | Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation. | 2014 Dec 11 |
1 |
| 71 |
22964640 | miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia. | 2013 Aug 1 |
1 |
| 72 |
23159843 | Rapid detection of PML-RARA fusion gene by novel high-speed droplet-reverse transcriptase-polymerase chain reaction: possibility for molecular diagnosis without lagging behind the morphological analyses. | 2013 Jan 16 |
1 |
| 73 |
23627671 | The short isoform of the long-type PML-RARA fusion gene in acute promyelocytic leukaemia lacks sensitivity to all-trans-retinoic acid. | 2013 Jul |
1 |
| 74 |
23670176 | Mechanisms of action and resistance to all-trans retinoic acid (ATRA) and arsenic trioxide (As2O 3) in acute promyelocytic leukemia. | 2013 Jun |
2 |
| 75 |
23998577 | Expression of PML-RARα is up-regulated during ATRA and arsenics combined induction without influence on long-term prognosis of acute promyelocytic leukemia. | 2013 Aug |
2 |
| 76 |
24344243 | Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia. | 2013 Dec 16 |
2 |
| 77 |
22406747 | Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. | 2012 Mar 11 |
2 |
| 78 |
22845560 | DNA methyltransferase inhibitor RG108 and histone deacetylase inhibitors cooperate to enhance NB4 cell differentiation and E-cadherin re-expression by chromatin remodelling. | 2012 Nov 1 |
1 |
| 79 |
22969967 | Interferon-γ enhances promyelocytic leukemia protein expression in acute promyelocytic cells and cooperates with all-trans-retinoic acid to induce maturation of NB4 and NB4-R1 cells. | 2012 May |
1 |
| 80 |
23049403 | Molecular basis for the diagnosis and treatment of acute promyelocytic leukemia. | 2012 |
1 |
| 81 |
23098119 | All-trans retinoic acid in the treatment of pediatric acute promyelocytic leukemia. | 2012 Sep |
2 |
| 82 |
23155234 | DNA methylation in ATRA-treated leukemia cell lines lacking a PML-RAR chromosome translocation. | 2012 Nov |
1 |
| 83 |
23300507 | Anti-PML-RARα shRNA sensitises promyelocytic leukaemia cells to all-trans retinoic acid. | 2012 |
2 |
| 84 |
21187718 | Autophagy regulates myeloid cell differentiation by p62/SQSTM1-mediated degradation of PML-RARα oncoprotein. | 2011 Apr |
3 |
| 85 |
21360626 | Promyelocytic leukemia protein in retinoic acid-induced chromatin remodeling of Oct4 gene promoter. | 2011 Apr |
2 |
| 86 |
21422471 | From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia. | 2011 Jun 16 |
1 |
| 87 |
21790894 | Advances in therapies for acute promyelocytic leukemia. | 2011 Nov |
2 |
| 88 |
21859732 | Clinical impact of FLT3 mutation load in acute promyelocytic leukemia with t(15;17)/PML-RARA. | 2011 Dec |
1 |
| 89 |
22040992 | [PML-RARα and p21 are key factors for maintaining acute promyelocytic leukemia stem cells survival]. | 2011 Oct |
2 |
| 90 |
22586354 | The drug-induced degradation of oncoproteins: an unexpected Achilles' heel of cancer cells? | 2011 Jul |
1 |
| 91 |
20084480 | Antiproliferative effect of 13-cis-retinoic acid is associated with granulocyte differentiation and decrease in cyclin B1 and Bcl-2 protein levels in G0/G1 arrested HL-60 cells. | 2010 Sep |
2 |
| 92 |
20224268 | Isochromosome der(17)(q10)t(15;17) in acute promyelocytic leukemia resulting in an additional copy of the RARA-PML fusion gene: report of 4 cases and review of the literature. | 2010 |
1 |
| 93 |
20455087 | Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting. | 2010 Jun |
2 |
| 94 |
20528759 | The impact of molecularly targeted therapies upon the understanding of leukemogenesis and the role of hematopoietic stem cell transplantation in acute promyelocytic leukemia. | 2010 Dec |
2 |
| 95 |
20574048 | Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein. | 2010 Sep 30 |
2 |
| 96 |
20615082 | Arsenic trioxide cooperates with all trans retinoic acid to enhance mitogen-activated protein kinase activation and differentiation in PML-RARalpha negative human myeloblastic leukemia cells. | 2010 Sep |
4 |
| 97 |
20935222 | Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML/RARα and inhibits the growth of acute promyelocytic leukemia. | 2010 Dec 1 |
4 |
| 98 |
19155306 | Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARalpha and PML-RARalpha. | 2009 Feb 1 |
1 |
| 99 |
19204783 | HDAC3 as a molecular chaperone for shuttling phosphorylated TR2 to PML: a novel deacetylase activity-independent function of HDAC3. | 2009 |
2 |
| 100 |
19273155 | PML nuclear bodies in the pathogenesis of acute promyelocytic leukemia: active players or innocent bystanders? | 2009 Jan 1 |
4 |